China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Correlation Study on Protein and Gene Expression Differences Between Osteoarthritis Pa... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Bioinformatics-Based Identification of Key Therapeutic Targets and Comprehensive Treat... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Functional Improvement and Brain Network Remodeling of Post-Stroke Cognitive Impairmen... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study of 68Ga-FAPI PET/CT imaging in malignant solid tumors'. The following a... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Recovery, composition analysis and reuse of the fluid after the recipient's own blood ... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Identification and Efficacy Evaluation of Minimal Residual Disease After Ablation of L... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and Validation of a Correlation Model for Carotid Atherosclerosis'. The fo... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Real-World Study of Biologic Treatments for Improving Asthma Control, Lung Function,... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Urethral Atresia Cohort Construction Project'. The following are the other relevant de... Read More
China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of First-line Treatment and Post-progression Treatment Patterns with PD-1/L1 ... Read More